Evidence map›Paper›PMID 39791769›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Investigating the ROS Formation and Particle Behavior of Food-Grade Titanium Dioxide (E171) in the TIM-1 Dynamic Gastrointestinal Digestion Model.

Nicolaj S Bischoff, Anna K Undas, Greet van Bemmel, Jacco J Briedé, Simone G van Breda, Jessica Verhoeven, Sanne Verbruggen, Koen Venema, Dick T H M Sijm, Theo M de Kok

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nicolaj S BischoffDepartment of Translational Genomics, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands.ORCID 0000-0001-5032-6314
Anna K UndasWageningen Food Safety Research (WFSR), Wageningen University & Research, 6708 WB Wageningen, The Netherlands.ORCID 0000-0003-4454-8767
Greet van BemmelWageningen Food Safety Research (WFSR), Wageningen University & Research, 6708 WB Wageningen, The Netherlands.ORCID 0009-0000-9986-5976
Jacco J BriedéDepartment of Translational Genomics, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands.ORCID 0000-0003-1405-5232
Simone G van BredaDepartment of Translational Genomics, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands.ORCID 0000-0003-1421-8214
Jessica VerhoevenCentre for Healthy Eating & Food Innovation, Maastricht University-Campus Venlo, Villafloraweg 1, 5928 SZ Venlo, The Netherlands.ORCID 0009-0008-3762-7508
Sanne VerbruggenCentre for Healthy Eating & Food Innovation, Maastricht University-Campus Venlo, Villafloraweg 1, 5928 SZ Venlo, The Netherlands.
Koen VenemaCentre for Healthy Eating & Food Innovation, Maastricht University-Campus Venlo, Villafloraweg 1, 5928 SZ Venlo, The Netherlands.ORCID 0000-0001-7046-5127
Dick T H M SijmDepartment of Pharmacology and Toxicology, Maastricht University, 6229 ER Maastricht, The Netherlands.ORCID 0000-0002-6726-1470
Theo M de KokDepartment of Translational Genomics, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands.

Funding

Maastricht University internal funding noneNVWA ARVODI-2018 Overeenkomst Onderzoeksopdracht E171
6 · The paper itself

Abstract

Food-grade titanium dioxide (E171) is widely used in food, feed, and pharmaceuticals for its opacifying and coloring properties. This study investigates the formation of reactive oxygen species (ROS) and the aggregation behavior of E171 using the TNO Gastrointestinal (GI) model, which simulates the stomach and small intestine. E171 was characterized using multiple techniques, including electron spin resonance spectroscopy, single-particle inductively coupled plasma-mass spectrometry, transmission electron microscopy, and dynamic light scattering. In an aqueous dispersion (E171-aq), E171 displayed a median particle size of 79 nm, with 73-75% of particles in the nano-size range (<100 nm), and significantly increased ROS production at concentrations of 0.22 and 20 mg/mL. In contrast, when E171 was mixed with yogurt (E171-yog), the particle size increased to 330 nm, with only 20% of nanoparticles, and ROS production was inhibited entirely. After GI digestion, the size of dE171-aq increased to 330 nm, while dE171-yog decreased to 290 nm, with both conditions showing a strongly reduced nanoparticle fraction. ROS formation was inhibited post-digestion in this cell-free environment, likely due to increased particle aggregation and protein corona formation. These findings highlight the innate potential of E171 to induce ROS and the need to consider GI digestion and food matrices in the hazard identification/characterization and risk assessment of E171.

Indexed as

agglomerationE171human gastrointestinal digestionphysicochemical characterizationROStitanium dioxide

Identifiers

PMID39791769
PMCPMC11721885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.